QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to 5-Fluorouracil
Related studies linked through entity extraction aliases.
QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Outpatient Performed Pterygium Surgery Study
- Status
- WITHDRAWN
- Phase
- PHASE4
Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients
- Status
- UNKNOWN
- Phase
- PHASE2
To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery
- Status
- COMPLETED
- Phase
- PHASE3
5-fluorouracil Versus Placebo in Periocular Full Thickness Skin Grafts
- Status
- COMPLETED
- Phase
- PHASE2
FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum
- Status
- COMPLETED
- Phase
- PHASE4
Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction
- Status
- COMPLETED
- Phase
- PHASE3